Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, U.P., India.
Department of Biotechnology, Graphic Era Hill University, Dehradun, India.
Curr Pharm Des. 2024;30(42):3311-3321. doi: 10.2174/0113816128324761240828064443.
Additive manufacturing, sometimes referred to as 3D printing or AM, has numerous applications in industries like manufacturing, aviation, aerospace, vehicles, and education. It has recently made considerable inroads into the healthcare industry, backed by technology breakthroughs such as fused deposition modeling, binder jetting, and inkjet printing. A variety of biomaterials, such as polycaprolactone, polycarbonate, polypropylene, and polylactic acid, have contributed to this increase. This essay delves into the revolutionary possibilities of 3D printing in healthcare, to shed light on the idea of customized medications via the improvement of efficiency and cost. Researchers are using polymers and additive manufacturing to make customized medical devices. However, obstacles including bureaucratic hurdles, technological developments, and the choice of appropriate materials and printers stand in the way of widespread implementation. To fully realize the promise of 3D printing in healthcare, these challenges must be overcome. The article highlights the revolutionary potential of 3D printing in healthcare by following its development from art and construction to customized drugs and patient-specific medical equipment. In addition to addressing issues like quality control and technological limitations, it emphasizes its wide range of applications in surgical planning, dentistry, and anatomical models. The necessity of adapting regulations and instructional programs is highlighted by discussing future trends like bioprinting and FDA-approved innovations. In order to properly utilize 3D printing in healthcare, this adaption is essential. Personalized prescriptions and increased efficacy from the incorporation of 3D printing could revolutionize the healthcare industry. But even with these advances, problems like choosing the right materials and getting over administrative roadblocks prevent widespread implementation. These challenges need to be successfully overcome for 3D printing in healthcare to reach its full potential.
增材制造，有时也被称为 3D 打印或 AM，在制造业、航空航天、汽车和教育等行业有着广泛的应用。最近，它在医疗保健行业取得了重大进展，得到了熔融沉积建模、粘结剂喷射和喷墨打印等技术突破的支持。多种生物材料，如聚己内酯、聚碳酸酯、聚丙烯和聚乳酸等，促成了这一增长。本文深入探讨了 3D 打印在医疗保健领域的革命性潜力，以阐明通过提高效率和降低成本来实现定制化药物的理念。研究人员正在使用聚合物和增材制造来制造定制化的医疗设备。然而，广泛实施面临着官僚主义障碍、技术发展以及合适材料和打印机选择等障碍。为了充分实现 3D 打印在医疗保健中的潜力，必须克服这些挑战。本文通过从艺术和建筑到定制化药物和患者特定医疗设备的发展，探讨了 3D 打印在医疗保健中的革命性潜力。除了解决质量控制和技术限制等问题外，它还强调了其在手术规划、牙科和解剖模型等广泛领域的应用。通过讨论生物打印和 FDA 批准的创新等未来趋势，强调了适应法规和教学计划的必要性。为了在医疗保健中正确利用 3D 打印，这种适应是必要的。通过将 3D 打印融入到个性化处方和提高疗效中，医疗保健行业可能会发生革命性的变化。但是，即使有了这些进步，选择合适的材料和克服行政障碍等问题仍阻止了其广泛应用。要使 3D 打印在医疗保健中充分发挥潜力，就必须成功克服这些挑战。
